Clinical Trial Update: Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating the combination of carboplatin and vinorelbine in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED